This shift is transforming the dynamic between patients and healthcare professionals (HCPs) and in turn, the decision-making ...

Boehringer Ingelheim and Cue Biopharma have announced a partnership worth $357m to develop and commercialise Cue’s ...

Merck & Co – known as MSD outside of the US and Canada – and Cyprumed have entered into a partnership aimed at developing ...

Exclusion from healthcare decisions can result from various barriers, including language, health literacy, cultural factors ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab) has been approved by the European Commission (EC). The ...

ET, join Medscape for a thought-provoking Afternoon Snack Session at CMEpalooza Spring 2025, titled “Reverse Planning with ...

As deadly as the measles outbreak in west Texas and New Mexico is the spread of vaccine conspiracy theories and misinformation. According to KFF research from ...

Johnson & Johnson (J&J) has received approval from the European Commission (EC) for its subcutaneous (SC) Darzalex (daratumumab)-based quadruplet regimen in newly diagnosed multiple myeloma (MM).

Equipping patients, carers and loved ones with the tools and understanding to make the choices that are right for them ...

Amgen has shared positive results from a late-stage study of its immunotherapy Imdelltra (tarlatamab-dlle) in small cell lung cancer (SCLC). The global DeLLphi-304 trial has been comparing the drug ...

Advanced melanoma patients in England are set to be fast-tracked into a clinical trial of a new skin cancer vaccine after the NHS partnered with Oxford-based Scancell to widen access across the ...

Point.1 Synthesis: smarter omni-channel planning to avoid wastage And lastly, we have Point.1 Synthesis, a product to aid brand experience activation. Synthesis uses Point.1 data touchpoint usage, ...